Health Canada has authorized the new Moderna Spikevax COVID-19 injection targeting the omicron XBB1.5 subvariant for those aged 6 months and up.
So how was this injection studied for safety and efficacy in those under 18?
Well, it wasn’t.
According to the National Institute of Health’s clinical trial data website, this study is not estimated to be complete until November 17, 2023. That’s nearly 12 weeks from the time of authorization.
So how can Health Canada make safety claims and recommendations?
Surely something has to be missing.
Yet just yesterday, Canada’s chief public health officer Dr. Theresa Tam endorsed the new mRNA booster for those aged six months and up.
Check back here for all the latest updates on Canada's pandemic response.
And if you're unhappy with Dr. Tam, please chime in and sign the petition on this page to call for her to be fired!
